Mild-to-moderate obstructive sleep apnea (OSA) is associated with an increased risk for hypertension and diabetes, preliminary data from two studies suggest.
“We found that even mild sleep apnea was strongly associated with increased risk of developing hypertension by 4 times compared to individuals without sleep apnea,” principal investigator, Alexandros N. Vgontzas, MD, from the Sleep Research & Treatment Center, Penn State University College of Medicine, Hershey, Pennsylvania, said in a news release. (read more)
According to the World Health Organization’s 2016 Global Report on Diabetes, the direct annual cost of the disease is around $827 billion. Additionally, the WHO says that diabetes is no longer a problem in wealthy countries, but is rapidly increasing in low—and moderate—income countries, accounting for nearly two-thirds of diabetes cases worldwide. In 2014, there were 422 million adults living with diabetes, which is a fourfold increase since 1980. (read more)
Millions of consumers are battling rising drug prices. But for diabetics who rely on daily medication, supplies and monitoring equipment, the problem can be particularly acute.
Just last month two major insulin manufacturers, Eli Lily (LLY) and Novo Nordisk (NVO), each raised their insulin prices by 8 percent. On Thursday, Nevada Republican Gov. Brian Sandoval signed a law that would require pharmaceutical companies to disclose how they set insulin prices. Meanwhile, Washington watchers are expecting President Donald Trump to soon issue at least one executive order aimed at lowering drug prices. (read more)